Q-Switched Pigment Machines
Q-switched lasers act on pigment particles with nanosecond photothermal pulses — the foundational platform for spot removal and tattoo removal: friendly purchase and consumables costs, high program awareness, the “base camp” of an institution’s pigment line.
Wavelength logic: ink color determines wavelength
1064nm penetrates deeper for dermal pigment and black/blue tattoo ink; 532nm treats superficial red-brown pigment; alexandrite 755nm has unique efficiency in some scenarios. Choose the wavelength combination by the pigment types common in your local client base. Layered treatment thinking: see the pigmentation program.
SYNIXFIELD pigment platforms
- Q-switched pigment laser: the Q-switched mainline for spots and tattoos
- HELIOS III dual-wavelength: a dual-wavelength combination covering more pigment types
- PicoStar picosecond: the upgrade path complementing Q-switched (see the picosecond page)
Program and compliance points
- Standardize the flow: spot assessment → wavelength choice → course design
- Quote tattoo removal by color and depth; manage expectations
- Marketing follows medical-advertising rules: describe principle and scope, no outcome promises
- Pigment-rebound management and sun-protection education are key to repeat visits and reputation
For a pigment-line combination, contact us.
FAQ
How do Q-switched and picosecond divide work in an institution?
Q-switched treats defined spots and tattoo ink via photothermal effects at lower purchase and consumables cost — the base of a pigment line; picosecond takes refined skin work and hard-to-treat pigment. When both are present, route by program difficulty.
Is an “eyebrow removal machine” just a Q-switched laser?
Tattoo-removal devices are dominated by Q-switched technology — 1064nm for black and blue ink, 532nm for red. The so-called eyebrow-removal machine is a Q-switched platform applied to microblading pigment.
What compliance wording matters for spot-removal programs?
Describe device principle and scope of use; avoid outcome promises and absolute claims; assess individual variation before treatment.